What are the treatment options for Chlamydia (sexually transmitted infection) and trichomoniasis (STI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chlamydia and Trichomoniasis

Chlamydia Treatment

For uncomplicated genital chlamydia, treat with either azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days, both with approximately 97-98% efficacy. 1, 2

First-Line Regimens

  • Azithromycin 1 g orally as a single dose is preferred when compliance is questionable, follow-up is unpredictable, or directly observed therapy is needed 1, 2
  • Doxycycline 100 mg orally twice daily for 7 days is equally effective, costs less, and has extensive clinical experience 1, 2
  • Meta-analyses confirm equal efficacy between these two regimens for genital chlamydial infections 2, 3

Alternative Regimens (when first-line options cannot be used)

  • Erythromycin base 500 mg orally four times daily for 7 days 4
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 4
  • Ofloxacin 300 mg orally twice daily for 7 days 4
  • Levofloxacin 500 mg orally once daily for 7 days 1

Important caveat: Erythromycin causes frequent gastrointestinal side effects that lead to poor compliance, making it a less desirable option 4, 2

Pregnancy Considerations

  • Azithromycin 1 g orally as a single dose is the preferred treatment during pregnancy 1, 2
  • Amoxicillin 500 mg orally three times daily for 7 days is an alternative 1, 2
  • Doxycycline, ofloxacin, and levofloxacin are contraindicated in pregnancy 1, 5
  • Pregnant women require test-of-cure 3 weeks after treatment completion due to potential maternal and neonatal complications 5

Pediatric Dosing

  • Children ≥8 years weighing >45 kg: Azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days 1
  • Children <45 kg: Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days 1
  • Avoid non-culture tests (EIA, DFA) in children due to false-positive results from cross-reaction with other organisms 1

Critical Management Steps

  • Dispense medications on-site when possible and directly observe the first dose to maximize compliance 1, 2
  • Patients must abstain from all sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen, and until all sex partners complete treatment 1, 2, 5
  • All sex partners from the preceding 60 days must be evaluated, tested, and treated simultaneously to prevent reinfection 1, 5
  • Test all patients for gonorrhea, syphilis, and HIV at the initial visit 1

Follow-Up and Retesting

  • Test-of-cure is NOT recommended for patients treated with recommended regimens unless compliance is questionable, symptoms persist, or reinfection is suspected 1, 2
  • Retest all women approximately 3 months after treatment due to high reinfection rates (84-92% of recurrent infections are reinfections, not treatment failures) 1, 5
  • If testing earlier than 3 weeks after treatment, false-positives may occur from dead organisms 5

Recurrent Chlamydia

  • Treat recurrent chlamydia with the same first-line regimens as initial infection (azithromycin 1 g single dose or doxycycline 100 mg twice daily for 7 days) 5
  • Treatment failure rates with recommended regimens are extremely low: 0-3% in males and 0-8% in females 2, 5
  • Most recurrences (84-92%) represent reinfection from untreated or new partners, not antibiotic resistance 5
  • The single most important factor in preventing recurrence is treating all sexual partners 5

Trichomoniasis Treatment

For trichomoniasis, treat with either metronidazole 2 g orally as a single dose OR tinidazole 2 g orally as a single dose, taken with food. 6, 7

First-Line Regimens

  • Tinidazole 2 g orally as a single dose with food is FDA-approved for trichomoniasis in both females and males 6
  • Metronidazole 2 g orally as a single dose is also effective for symptomatic trichomoniasis 7
  • Both medications should be taken with food to minimize gastrointestinal side effects 6

Critical Management Steps

  • Sexual partners must be treated simultaneously with the same dose to prevent reinfection, as trichomoniasis is a sexually transmitted disease 6, 7
  • Patients must avoid alcoholic beverages during treatment and for 3 days afterward when taking tinidazole 6
  • Asymptomatic male partners should be treated even with negative cultures, as the organism is difficult to isolate from male carriers 7

Alternative Dosing for Tinidazole

  • Tinidazole 2 g orally once daily for 2 days with food (for bacterial vaginosis, but may be considered) 6
  • Tinidazole 1 g orally once daily for 5 days with food (for bacterial vaginosis, but may be considered) 6

Special Considerations

  • For patients unable to swallow tablets, tinidazole tablets may be crushed in artificial cherry syrup (stable for 7 days at room temperature) 6
  • Rule out other pathogens including Chlamydia trachomatis, Neisseria gonorrhoeae, Candida albicans, and Herpes simplex virus before diagnosing trichomoniasis 6
  • Asymptomatic female partners should be treated when the organism is associated with endocervicitis, cervicitis, or cervical erosion 7

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Recurrent Chlamydia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.